According to researchers at the University of Queensland located in Australia, cannabidiol can kill a range of bacteria harmful to the body, including those causing meningitis, gonorrhea or Legionnaires’ disease. Moreover, the research plan between UQ and Botanix Pharmaceuticals Limited (ASX: BOT) could lead to the development of antibiotics that can combat bacteria that are resistant to traditional drugs.
Meanwhile, for gram-negative infections, no new molecular class has yet been discovered for clinical use for more than 50 years or so. Mark Blaskovich, associate professor at UQ’s Institute for Molecular Bioscience commented on this: “This is the first time that CBD has been shown to kill some types of gram-negative bacteria. Likewise he indicated “These bacteria have an additional outer membrane, an additional line of defense that makes it difficult for antibiotics to penetrate”.
In view of this, Blaskovich commented “It is believed that the action of cannabidiol involves bursting the outer cell membranes of bacteria, but it is not yet clear how this occurs and more research is needed” . CBD, in this circumstance, a synthetic type of cannabidiol, was also effective in breaking down biofilms that help some types of bacteria survive antibiotic treatments.